Managing Challenging Behaviour in Brain Tumour (BT) Patients
Managing patients with brain tumours is not confined to best surgical, radiotherapeutic and chemotherapeutic practices, but also involves the management of behavioural changes that arise from different causes and at different time points of the disease.
These behavioural changes need to be managed and considered from different perspectives; they can also affect the patient’s interactions with health care professionals and carers and can affect the patient’s social interactions.
This chapter will discuss four main causes of behavioural disorders in patients with brain tumours, which can be (1) due to focal or diffuse brain damage, (2) psychiatric effects (3) seizures, (4) the effects of tumour treatment and the overlapping of several different causes.
The time course of malignant brain tumours is usually stereotyped and involves the time of diagnosis, the treatment period, a phase of progression with cognitive decline and an end-of-life phase.
The behavioural changes of brain tumour patients are important not only for the patients and their carers, but also for their interactions with health care professionals and other social contacts. Although the behavioural changes can be directly caused by the strategic localization of the brain tumour, several other causes need to be considered and defined in regard to the selection of therapeutic interventions.
Conflict of Interest
The authors report no conflict of interest and have contributed equally to the chapter.
- 2.Kübler-Ross E. On death and dying. London: Routledge; 1969. ISBN 0-415-04015-9.Google Scholar
- 20.Munjal S, Pahlajani S, Baxi A, Ferrando S. Delayed diagnosis of glioblastoma multiforme presenting with atypical psychiatric symptoms. Prim Care Companion CNS Disord. 2016;18:6.Google Scholar
- 24.Confusion: delirium and dementia. http://www.victoriahospice.org/sites/default/files/imce/Delirium-Section-MedCareOfDying.pdf. p. 455–83.
- 45.Simoa M, Rifa-Rosa X, Rodriguez-Fornellsa A, Bruna J. Chemobrain: a systematic review of structural and functional neuroimaging studies. Neurosci Biobehav Rev. 2013;37(8):1311–21.Google Scholar
- 56.Bush SH, Kanji S, Pereira JL, Davis DHJ, Currow DC, Meagher D, Rabheru K, Wright D, Bruera E, Hartwick M, Gagnon PR, Gagnon B, Breitbart W, Regnier L, Lawlor PG. Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future development. J Pain Symptom Manag. 2014;48:231–48.CrossRefGoogle Scholar
- 57.Pace A, Dirven L, Koekkoek JAF, Golla H, Fleming J, Ruda R, Marosi C, Le Rhun E, Grant R, Oliver K, Oberg I, Bulbeck HJ, Rooney AG, Henriksson R, Pasman HRW, Oberndorfer S, Weller M, Taphoorn MJB, European Association of Neuro-Oncology Palliative Care Task Force. European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma. Lancet Oncol. 2017;18:e330–40.CrossRefGoogle Scholar
- 60.Kübler-Ross E. On grief and grieving: finding the meaning of grief through the five stages of loss. London: Simon & Schuster; 2005.Google Scholar
- 65.Cetrano G, Tedeschi F, Rabbi L, Gosetti G, Lora A, Lamonaca D, Manthorpe J, Amaddeo F. How are compassion fatigue, burnout, and compassion satisfaction affected by quality of working life? Findings from a survey of mental health staff in Italy. BMC Health Serv Res. 2017;17:755. https://doi.org/10.1186/s12913-017-2726-x.CrossRefPubMedPubMedCentralGoogle Scholar